First adult patient with fibrosing colonopathy

American Journal of Gastroenterology

Volumn 93, Issue 7, 1998, Pages 1171-1172

  Hausler M ^a,b   Meilicke, R ^a   Biesterfeld, S ^a   Heimann, G ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PANZYTRAT;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CASE REPORT; COLON DISEASE; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DOSE RESPONSE; ENZYME THERAPY; FEMALE; HUMAN; LAPAROTOMY; MORBIDITY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; TOTAL PARENTERAL NUTRITION;

ABDOMINAL PAIN; ADULT; COLECTOMY; COLON; CYSTIC FIBROSIS; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; ISCHEMIA; PANCREATIN;

EID: 0345683489     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(98)00236-6     Document Type: Article

References (10)

1. 1. Smyth RL, van Velzen D, Smyth AR, et al. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes [see comments]. Lancet 1994;343:85-6.
2. 2. Smyth RL, Ashby D, O'Hea U, et al. Fibrosing colonopathy in cystic fibrosis: Results of a case-control study. Lancet 1995;346:1247-51.
3. 3. FitzSimmons SC, Burkhart GA, Borowitz D, et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997;336:1283-9.
4. 4. Schwarzenberg SJ, Wielinski CL, Shamieh I, et al. Cystic fibrosis-associated colitis and fibrosing colonopathy. J Pediatr 1995;127:565-70.
5. 5. Dodge JA. The aetiology of fibrosing colonopathy. Postgrad Med J 1996;72(suppl 2):S52-5:S52-5.
6. 6. van Velzen D, Ball LM, Dezfulian AR, et al. Comparative and experimental pathology of fibrosing colonopathy. Postgrad Med J 1996; 72(suppl 2):S39-48.
7. 7. Pawel BR, de Chadarevian JP, Franco ME. The pathology of fibrosing colonopathy of cystic fibrosis: A study of 12 cases and review of the literature. Hum Pathol 1997;28:395-9.
8. 8. Croft NM, Marshall TG, Ferguson A. Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements [see comments]. Lancet 1995;346:1265-7.
9. 9. Park RW, Grand RJ. Gastrointestinal manifestations of cystic fibrosis: A review. Gastroenterology 1981;81:1143-61.
10. 10. Briars GL, Griffiths DM, Moore IE, et al. High-strength pancreatic enzymes [letter]. Lancet 1994;343:600.